Menu

News & Insights

  • Clear

Drug Distributors and Major Pharmaceutical Company Reach $26 Billion Global Settlement with States to End Opioid Litigation

A bipartisan group of AGs reached a $26 billion global settlement with three major drug distributors and Johnson & Johnson (“J&J”) (collectively “Companies”), pending approval by the vast majority of states and municipalities, to release the Companies from all civil liability relating to the opioid crisis.

Read More

Nebraska Attorney General Asked to Weigh In on Legality of Delta-8

July 20, 2021. Senate Majority Leader Chuck Schumer reinvigorated the federal marijuana debate last week with the introduction of his Cannabis Administration and Opportunity Act, which seeks to de-schedule cannabis and regulate cannabis sales, possession and use in a manner that balances individual liberty with public health and safety.

Read More

In South Dakota, the AG and the Governor Are Sparring. What Does this Mean for Marijuana Deregulation in Other States?

As marijuana legalization rolls out across the nation, state AGs will play a critical role in the interpretation and development of marijuana policy and enforcement. In this Cannabis Business Executive article “In South Dakota, the AG and the Governor Are Sparring. What Does this Mean for Marijuana Deregulation in Other States?”, State AG Group members…

Read More

J&J Settles Opioid-Related New York Suit for $230 Million

New York AG Letitia James reached a settlement with Johnson & Johnson (“J&J”) to resolve allegations that J&J’s activities relating to its manufacture and distribution of opioids caused public nuisance, amounted to common-law fraud, and violated the New York Controlled Substance Act and New York’s consumer protection and finance laws.

Read More